Search This Blog

Thursday, November 5, 2026

Veracyte resets Decipher growth outlook

 

issues preliminary 2027 guide for mid-single-digit revenue growth and ~22% adjusted EBITDA margin after Q3 beat

  • Non-GAAP EPS $0.51 in fiscal Q3 2026 was flat year over year (+0% YoY).
  • Q3 2026 revenue was $151.8M, up 15% year over year and above analyst expectations.
  • Company slightly tightened its full-year 2026 revenue guidance range to $590–$593 million.
  • $100M share repurchase program announced alongside Q3 2026 results today.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.